Terms: = Ovarian cancer AND B2M, P61769, 567, ENSG00000166710 AND Diagnosis
11 results:
1. Differences between complex epithelial neoplasms of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study.
Li X; Ding Y; Liu Y; Yang M
J Ovarian Res; 2022 Dec; 15(1):125. PubMed ID: 36456989
[TBL] [Abstract] [Full Text] [Related]
2. Base amount-dependent fluorescence enhancement for the assay of vascular endothelial growth factor 165 in human serum using hairpin DNA-silver nanoclusters and oxidized carbon nanoparticles.
Ji J; Xu X; Chen P; Wu J; Jin Y; Zhang L; Du S
Mikrochim Acta; 2020 Oct; 187(11):629. PubMed ID: 33123813
[TBL] [Abstract] [Full Text] [Related]
3. New sonographic morphology score for the differentiation of malignant from benign ovarian tumors.
Shen ZY; He AQ; Xia GL; Wu MF; Li J; Ding YS
J Obstet Gynaecol Res; 2016 Aug; 42(8):1000-12. PubMed ID: 27125323
[TBL] [Abstract] [Full Text] [Related]
4. The clinical impact of gynecologic MRI.
Ratner ES; Staib LH; Cross SN; Raji R; Schwartz PE; McCarthy SM
AJR Am J Roentgenol; 2015 Mar; 204(3):674-80. PubMed ID: 25714302
[TBL] [Abstract] [Full Text] [Related]
5. Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer.
Grimm C; Hofstetter G; Aust S; Mutz-Dehbalaie I; Bruch M; Heinze G; Rahhal-Schupp J; Reinthaller A; Concin N; Polterauer S
Br J Cancer; 2013 Aug; 109(3):610-4. PubMed ID: 23921280
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract] [Full Text] [Related]
7. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population.
Lavie O; Narod S; Lejbkowicz F; Dishon S; Goldberg Y; Gemer O; Rennert G
Ann Oncol; 2011 Apr; 22(4):964-966. PubMed ID: 20924075
[TBL] [Abstract] [Full Text] [Related]
8. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2010 Jan; 116(1):57-60. PubMed ID: 19818996
[TBL] [Abstract] [Full Text] [Related]
9. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.
Hughes KS; Roche C; Campbell CT; Siegel N; Salisbury L; Chekos A; Katz MS; Edell E
Breast J; 2003; 9(1):19-25. PubMed ID: 12558666
[TBL] [Abstract] [Full Text] [Related]
11. Treatment strategies of the borderline ovarian tumors.
Bulletti C; Albonetti A; Talamo T; Reggiani LB; Giacomucci E; Alfieri S; Flamigni C
Front Biosci; 1996 Dec; 1():g12-3. PubMed ID: 9159260
[TBL] [Abstract] [Full Text] [Related]
